Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Girish Vyas, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentLaboratory Medicine
    Address521 Parnassus Ave, Clinic Sci
    San Francisco CA 94143
    Phone415-476-4678

       Overview 
       Overview
      Girish N. Vyas, Ph.D. recently completed his sabbatical leave in the UCLA Department of Pediatrics. He currently serves as Professor of Laboratory Medicine. After receiving his Ph.D. degree in Microbiology from the University of Bombay in 1965, he completed a postdoctoral research fellowship at Western Reserve University in Cleveland, Ohio. In 1967 he joined UCSF as a Lecturer in the Department of Medicine. He served as Director of Blood Bank at UCSF Medical Center from 1969-89. His seminal contributions to our current knowledge about transfusion safety, IgA deficiency, viral hepatitis B, and transfusion-transmitted HIV have culminated in his current pursuit of research on in vitro genetic diversification of prevalent HIV-1 strains co-cultured in CD4-enriched pools of human PBMC for developing an inactivated polyvalent HIV-envelope subunit vaccine against HIV-1 infection. Dr. Vyas has served on several committees of NAS-NRC, NIH, CDC, FDA, WHO, AABB, ASH, and UNDP. As an American Fulbright Scholar he worked on the molecular biology of hepatitis B virus at the Pasteur Institute in 1980. He is currently the Chairman of the IABS Publications Committee and Editor-in-Chief for BIOLOGICALS. He has edited 12 books and monographs and published 220 original papers on his research in genetics and virology related to Transfusion Medicine.


       ORNG Applications 
       Websites
       Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Killian MS, Vyas GN, Mehta R, Young K, Ebrahim O. Possible transmission of human immunodeficiency virus-1 infection from an elite controller to a patient who progressed to acquired immunodeficiency syndrome: a case report. J Med Case Rep. 2012; 6(1):291.
        View in: PubMed
      2. Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion. 2012 May; 52 Suppl 1:65S-79S.
        View in: PubMed
      3. Vyas GN, Grady GF. The life and legacy of Alfred M. Prince, M. D. (1928-2011). Biologicals. 2012 Jan; 40(1):1-2.
        View in: PubMed
      4. Vyas GN, Stoddart CA, Killian MS, Brennan TV, Goldberg T, Ziman A, Bryson Y. Derivation of non-infectious envelope proteins from virions isolated from plasma negative for HIV antibodies. Biologicals. 2012 Jan; 40(1):15-20.
        View in: PubMed
      5. Lai-Hipp C, Goldberg T, Scott E, Ziman A, Vyas G. Pooled peripheral blood mononuclear cells provide an optimized cellular substrate for human immunodeficiency virus Type 1 isolation during acute infection. Transfusion. 2011 Feb; 51(2):333-7.
        View in: PubMed
      6. Vyas GN. Unconventional journals: research ramifications. Science. 2010 Apr 23; 328(5977):427.
        View in: PubMed
      7. Dodd R, Kurt Roth W, Ashford P, Dax EM, Vyas G. Transfusion medicine and safety. Biologicals. 2009 Apr; 37(2):62-70.
        View in: PubMed
      8. Stiehm ER, Keller MA, Vyas GN. Preparation and use of therapeutic antibodies primarily of human origin. Biologicals. 2008 Nov; 36(6):363-74.
        View in: PubMed
      9. Vyas GN. Participating in the evolution of transfusion medicine from a dispensary into a discipline. Transfus Med Rev. 2008 Apr; 22(2):162-7.
        View in: PubMed
      10. Leong M, Babbitt W, Vyas G. A hollow-fiber bioreactor for expanding HIV-1 in human lymphocytes used in preparing an inactivated vaccine candidate. Biologicals. 2007 Oct; 35(4):227-33.
        View in: PubMed
      11. Grady GF, Vyas GN. Blood-transmitted prions and variant Creutzfeldt-Jakob disease. Biologicals. 2007 Apr; 35(2):75-7.
        View in: PubMed
      12. Terrault NA, Vyas G. Hepatitis B immune globulin preparations and use in liver transplantation. Clin Liver Dis. 2003 Aug; 7(3):537-50.
        View in: PubMed
      13. Vyas GN. Human peripheral blood mononuclear cell substrate for propagating wild type HIV-1. Dev Biol (Basel). 2001; 106:345-56; discussion 356-7.
        View in: PubMed
      14. Gandhi MJ, Yang GG, McMahon BJ, Vyas GN. Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted. Transfusion. 2000 Aug; 40(8):910-6.
        View in: PubMed
      15. Vyas GN. Immunobiology of persistent blood-borne viral infections. Dev Biol (Basel). 2000; 102:9-17.
        View in: PubMed
      16. Gandhi MJ, Boyd MR, Yi L, Yang GG, Vyas GN. Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N). Dev Biol (Basel). 2000; 102:141-8.
        View in: PubMed
      17. Murphy EL, Busch MP, Tong M, Cornett P, Vyas GN. A prospective study of the risk of transfusion-acquired viral infections. Transfus Med. 1998 Sep; 8(3):173-8.
        View in: PubMed
      18. Yang G, D'Souza MP, Vyas GN. Neutralizing antibodies against HIV determined by amplification of viral long terminal repeat sequences from cells infected in vitro by nonneutralized virions. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jan 1; 17(1):27-34.
        View in: PubMed
      19. Dorenbaum A, Venkateswaran KS, Yang G, Comeau AM, Wara D, Vyas GN. Transmission of HIV-1 in infants born to seropositive mothers: PCR-amplified proviral DNA detected by flow cytometric analysis of immunoreactive beads. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1; 15(1):35-42.
        View in: PubMed
      20. Gelb AB, Venkateswaran KS, Vyas GN. Editorial summary of the Pre-symposium workshop on the Contemporary Assessment of Technologies. Biologicals. 1996 Sep; 24(3):177-86.
        View in: PubMed
      21. Rawal BD, Vyas GN. Magnesium-mediated reversal of the apparent virucidal effect of ascorbic acid or congo red reacted in vitro with the human immunodeficiency virus. Biologicals. 1996 Jun; 24(2):113-6.
        View in: PubMed
      22. Yang G, Vyas GN. Immunodiagnosis of viral hepatitides A to E and non-A to -E. Clin Diagn Lab Immunol. 1996 May; 3(3):247-56.
        View in: PubMed
      23. Vyas GN, Rawal BD. The risk of HIV transmission by screened blood. N Engl J Med. 1996 Apr 11; 334(15):992; author reply 993.
        View in: PubMed
      24. Prati D, Brandwein H, Capelli C, Dzik WH, Masse M, Myllylä G, Stromberg RR, Takahashi T, Vyas GN, Wenz B. Multicenter evaluation of the 3% paraformaldehyde method for white cell counting in leukocyte-reduced red blood cells. BEST (Biomedical Excellence for Safer Transfusion) Working Party of the International Society of Blood Transfusion. Vox Sang. 1996; 70(4):241-5.
        View in: PubMed
      25. Yang G, Olson JC, Pu R, Vyas GN. Flow cytometric detection of human immunodeficiency virus type 1 proviral DNA by the polymerase chain reaction incorporating digoxigenin- or fluorescein-labeled dUTP. Cytometry. 1995 Oct 1; 21(2):197-202.
        View in: PubMed
      26. Vyas GN. Inactivation and removal of blood-borne viruses. Transfusion. 1995 May; 35(5):367-70.
        View in: PubMed
      27. Rawal BD, Bartolini F, Vyas GN. In vitro inactivation of human immunodeficiency virus by ascorbic acid. Biologicals. 1995 Mar; 23(1):75-81.
        View in: PubMed
      28. Prati D, Rawal BD, Dang C, Capelli C, Vyas GN. DNA enzyme immunoassay of the PCR-amplified HLA-DQ alpha gene for estimating residual leukocytes in filtered blood. Clin Diagn Lab Immunol. 1995 Mar; 2(2):182-5.
        View in: PubMed
      29. Vyas GN, Yang G, Murphy EL. Transfusion-related transmissible diseases: detection by polymerase chain reaction-amplified genes of the microbial agents. Transfus Med Rev. 1994 Oct; 8(4):253-66.
        View in: PubMed
      30. Sankary TM, Yang G, Romeo JM, Ulrich PP, Busch MP, Rawal BD, Vyas GN. Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase. Transfusion. 1994 Aug; 34(8):656-60.
        View in: PubMed
      31. Yang G, Garhwal S, Olson JC, Vyas GN. Flow cytometric immunodetection of human immunodeficiency virus type 1 proviral DNA by heminested PCR and digoxigenin-labeled probes. Clin Diagn Lab Immunol. 1994 Jan; 1(1):26-31.
        View in: PubMed
      32. Gong J, Rawal BD, Högman CF, Vyas GN, Nilsson B, Gustafsson I. Complement killing of Yersinia enterocolitica and retention of the bacteria by leucocyte removal filters. Vox Sang. 1994; 66(3):166-70.
        View in: PubMed
      33. Babu PG, Rawal BD, Khayam-Bashi H, Vyas GN. Detection of exceedingly low levels of HIV proviral DNA in multimillion peripheral blood mononuclear cells by PCR. PCR Methods Appl. 1993 Aug; 3(1):63-4.
        View in: PubMed
      34. Rawal BD, Vyas GN. Complement-mediated bactericidal action and the removal of Yersinia enterocolitica by white cell filters. Transfusion. 1993 Jun; 33(6):536.
        View in: PubMed
      35. Vyas GN. Molecular approaches to the detection of agents in persistent viral infections. Indian J Med Sci. 1993 Apr; 47(4):103-8.
        View in: PubMed
      36. Yang G, Ulrich PP, Aiyer RA, Rawal BD, Vyas GN. Detection of hepatitis B virus in plasma using flow cytometric analyses of polymerase chain reaction-amplified DNA incorporating digoxigenin-11-dUTP. Blood. 1993 Feb 15; 81(4):1083-8.
        View in: PubMed
      37. Romeo JM, Ulrich PP, Busch MP, Vyas GN. Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors. Hepatology. 1993 Feb; 17(2):188-95.
        View in: PubMed
      38. Ulrich PP, Romeo JM, Daniel LJ, Vyas GN. An improved method for the detection of hepatitis C virus RNA in plasma utilizing heminested primers and internal control RNA. PCR Methods Appl. 1993 Feb; 2(3):241-9.
        View in: PubMed
      39. Eble BE, Busch MP, Khayam-Bashi H, Nason MA, Samson S, Vyas GN. Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate donors and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-prevalence area. Transfusion. 1992 Jul-Aug; 32(6):503-8.
        View in: PubMed
      40. Romeo JM, Ulrich PP, Vyas GN. Hepatitis C virus detection in blood donors. Transfusion. 1991 Oct; 31(8):780.
        View in: PubMed
      41. Busch MP, Eble BE, Khayam-Bashi H, Heilbron D, Murphy EL, Kwok S, Sninsky J, Perkins HA, Vyas GN. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med. 1991 Jul 4; 325(1):1-5.
        View in: PubMed
      42. Weintrub PS, Ulrich PP, Edwards JR, Boucher F, Levy JA, Cowan MJ, Vyas GN. Use of polymerase chain reaction for the early detection of HIV infection in the infants of HIV-seropositive women. AIDS. 1991 Jul; 5(7):881-4.
        View in: PubMed
      43. Rawal B, Yen TS, Vyas GN, Busch M. Leukocyte filtration removes infectious particulate debris but not free virus derived from experimentally lysed HIV-infected cells. Vox Sang. 1991; 60(4):214-8.
        View in: PubMed
      44. Lee HS, Ulrich PP, Vyas GN. Mutations in the S-gene affecting the immunologic determinants of the envelope protein of hepatitis B virus. J Hepatol. 1991; 13 Suppl 4:S97-101.
        View in: PubMed
      45. Rawal BD, Schwadron R, Busch MP, Endow R, Vyas GN. Evaluation of leukocyte removal filters modelled by use of HIV-infected cells and DNA amplification. Blood. 1990 Nov 15; 76(10):2159-61.
        View in: PubMed
      46. Ulrich PP, Romeo JM, Lane PK, Kelly I, Daniel LJ, Vyas GN. Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest. 1990 Nov; 86(5):1609-14.
        View in: PubMed
      47. Vyas GN. [Effective use of hepatitis tests]. Taehan Kanho. 1990 Oct 31; 29(4):38-43.
        View in: PubMed
      48. Ulrich PP, Bhat RA, Kelly I, Brunetto MR, Bonino F, Vyas GN. A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease. J Med Virol. 1990 Oct; 32(2):109-18.
        View in: PubMed
      49. Rawal BD, Davis RE, Busch MP, Vyas GN. Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection. Transfus Med Rev. 1990 Oct; 4(4 Suppl 1):36-41.
        View in: PubMed
      50. Bhat RA, Ulrich PP, Vyas GN. Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man. Hepatology. 1990 Feb; 11(2):271-6.
        View in: PubMed
      51. Roy S, Morrow WJ, Christian C, Khayam-Bashi H, Busch MP, McCarthy R, Rodgers RP, Vyas GN. Persistent immune complexes and abnormal CD4/CD8 ratios in HIV infection. J Acquir Immune Defic Syndr. 1990; 3(2):134-8.
        View in: PubMed
      52. Lee HS, Sarosi I, Vyas GN. Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology. 1989 Nov; 97(5):1281-7.
        View in: PubMed
      53. Edwards JR, Ulrich PP, Weintrub PS, Cowan MJ, Levy JA, Wara DW, Vyas GN. Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. J Pediatr. 1989 Aug; 115(2):200-3.
        View in: PubMed
      54. Ulrich PP, Bhat RA, Seto B, Mack D, Sninsky J, Vyas GN. Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J Infect Dis. 1989 Jul; 160(1):37-43.
        View in: PubMed
      55. Rawal BD, Busch MP, Endow R, Garcia-de-Lomas J, Perkins HA, Schwadron R, Vyas GN. Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration. Transfusion. 1989 Jun; 29(5):460-2.
        View in: PubMed
      56. Scillian JJ, McHugh TM, Busch MP, Tam M, Fulwyler MJ, Chien DY, Vyas GN. Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay. Blood. 1989 May 15; 73(7):2041-8.
        View in: PubMed
      57. Blum HE, Gerok W, Vyas GN. The molecular biology of hepatitis B virus. Trends Genet. 1989 May; 5(5):154-8.
        View in: PubMed
      58. Hwang LY, Beasley RP, Busch MP, Lane PK, Vyas GN. Human immunodeficiency virus seroprevalence among blood product recipients in San Francisco before transfusion. Transfusion. 1989 Feb; 29(2):113-8.
        View in: PubMed
      59. Lai ME, Farci P, Figus A, Balestrieri A, Arnone M, Vyas GN. Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood. 1989 Jan; 73(1):17-9.
        View in: PubMed
      60. Vyas GN. Other virus infections in AIDS. IV. AIDS and hepatitis B virus infection. Immunol Ser. 1989; 44:564-7.
        View in: PubMed
      61. Vyas GN. Symposium on transfusion-associated infections and immune response. Transfus Med Rev. 1988 Dec; 2(4):193-5.
        View in: PubMed
      62. Oexle K, Bhat RA, Vyas GN. Biology of hepatitis delta virus. Transfus Med Rev. 1988 Dec; 2(4):221-3.
        View in: PubMed
      63. Lee HS, Rajagopalan MS, Vyas GN. A lack of direct role of hepatitis B virus in the activation of ras and c-myc oncogenes in human hepatocellular carcinogenesis. Hepatology. 1988 Sep-Oct; 8(5):1116-20.
        View in: PubMed
      64. Calman AF, Busch MP, Vyas GN, McHugh TM, Stites DP, Peterlin BM. Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro. AIDS. 1988 Jun; 2(3):185-93.
        View in: PubMed
      65. Ulrich PP, Busch MP, el-Beik T, Shiota J, Vennari J, Shriver K, Vyas GN. Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects. J Med Virol. 1988 May; 25(1):1-10.
        View in: PubMed
      66. Gjerset GF, Vyas GN, Bhat R, Operskalski EA. Phenotypes for group-specific component among patients exposed to human immunodeficiency virus by transfusions. J Infect Dis. 1988 Mar; 157(3):609-10.
        View in: PubMed
      67. Lee HS, Vyas GN. Diagnosis of viral hepatitis. Clin Lab Med. 1987 Dec; 7(4):741-57.
        View in: PubMed
      68. Busch MP, Rajagopalan MS, Gantz DM, Fu S, Steimer KS, Vyas GN. In situ hybridization and immunocytochemistry for improved assessment of human immunodeficiency virus cultures. Am J Clin Pathol. 1987 Dec; 88(6):673-80.
        View in: PubMed
      69. Stevens CE, Taylor PE, Tong MJ, Toy PT, Vyas GN, Nair PV, Weissman JY, Krugman S. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA. 1987 May 15; 257(19):2612-6.
        View in: PubMed
      70. Lee HS, Rajagopalan MS, Chien D, Cordell R, Perkins HA, Vyas GN. Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors. Transfusion. 1987 Jan-Feb; 27(1):103-6.
        View in: PubMed
      71. Rajagopalan MS, Busch MP, Blum HE, Vyas GN. Interaction of aflatoxin and hepatitis B virus in the pathogenesis of hepatocellular carcinoma. Life Sci. 1986 Oct 6; 39(14):1287-90.
        View in: PubMed
      72. Stevens CE, Taylor PE, Tong MJ, Toy PT, Vyas GN. Yeast recombinant hepatitis B vaccine in perinatal hepatitis B virus transmission: a preliminary report. J Infect. 1986 Jul; 13 Suppl A:13.
        View in: PubMed
      73. Vyas GN. A brief overview of the new vaccines against hepatitis B virus infection: immunogenic gene products and peptide analogues of antigenic epitopes. Dev Biol Stand. 1986; 63:141-6.
        View in: PubMed
      74. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, Gudavalli M, Krugman S. Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA. 1985 Mar 22-29; 253(12):1740-5.
        View in: PubMed
      75. Blum HE, Figus A, Haase AT, Vyas GN. Laboratory diagnosis of hepatitis B virus infection by nucleic acid hybridization analyses and immunohistologic detection of gene products. Dev Biol Stand. 1985; 59:125-39.
        View in: PubMed
      76. Blum HE, Haase AT, Harris JD, Walker D, Vyas GN. Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology. 1984 Nov; 139(1):87-96.
        View in: PubMed
      77. Blum HE, Haase AT, Vyas GN. Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet. 1984 Oct 6; 2(8406):771-5.
        View in: PubMed
      78. Vyas GN, Blum HE. Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med. 1984 May; 140(5):754-62.
        View in: PubMed
      79. Figus A, Blum HE, Vyas GN, De Virgilis S, Cao A, Lippi M, Lai E, Balestrieri A. Hepatitis B viral nucleotide sequences in non-A, non-B or hepatitis B virus-related chronic liver disease. Hepatology. 1984 May-Jun; 4(3):364-8.
        View in: PubMed
      80. Blum HE, Stowring L, Figus A, Montgomery CK, Haase AT, Vyas GN. Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A. 1983 Nov; 80(21):6685-8.
        View in: PubMed
      81. Blum HE, Vyas GN. Hepatitis B virus in non-hepatocytes. Lancet. 1983 Oct 15; 2(8355):920.
        View in: PubMed
      82. Ganem D, Vyas GN. Laboratory diagnosis of viral hepatitis. Geriatrics. 1983 Mar; 38(3):97-103, 107-8.
        View in: PubMed
      83. Vyas GN, Bhatnagar PK, Blum HE, Expose J, Heldebrandt CM. Appraisal and prospects of a dimeric synthetic peptide coupled with tetanus toxoid for a bifunctional vaccine against hepatitis B virus infection. Dev Biol Stand. 1983; 54:93-102.
        View in: PubMed
      84. Bhatnagar PK, Papas E, Blum HE, Milich DR, Nitecki D, Karels MJ, Vyas GN. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A. 1982 Jul; 79(14):4400-4.
        View in: PubMed
      85. Vyas GN, Perkins HA. Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood. N Engl J Med. 1982 Mar 25; 306(12):749-50.
        View in: PubMed
      86. Blum HE, Vyas GN. Non-A, non-B hepatitis: a contemporary assessment. Haematologia (Budap). 1982; 15(2):153-73.
        View in: PubMed
      87. Milich DR, Gottfried TD, Vyas GN. Characterization of the interaction between polymerized human albumin and hepatitis B surface antigen. Gastroenterology. 1981 Aug; 81(2):218-25.
        View in: PubMed
      88. Tiollais P, Charnay P, Vyas GN. Biology of hepatitis B virus. Science. 1981 Jul 24; 213(4506):406-11.
        View in: PubMed
      89. Bréchot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A. 1981 Jun; 78(6):3906-10.
        View in: PubMed
      90. Chien MC, Tong MJ, Lo KJ, Lee JK, Milich DR, Vyas GN, Murphy BL. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan. J Natl Cancer Inst. 1981 Mar; 66(3):475-9.
        View in: PubMed
      91. Baxi AJ, Bhatia HM, Dutta RN, John TJ, Joshi SH, Kulkarni KV, Nayak NC, Pal SR, Vyas GN. Comparative data on the detection of hepatitis-B surface antigen by six centres. Indian J Med Res. 1981 Feb; 73:255-7.
        View in: PubMed
      92. Milich DR, Bhatnagar PK, Papas ED, Vyas GN. Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: II. Involvement of Clq in or near the hepatitis B surface antigen receptor for polyalbumin. J Med Virol. 1981; 7(3):193-204.
        View in: PubMed
      93. Milich DR, Papas ED, Bhatnagar PK, Vyas GN. Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: I. Binding of polyalbumin to Clq. J Med Virol. 1981; 7(3):181-92.
        View in: PubMed
      94. Milich DR, Vyas GN, Holland PV, Couroucé-Pauty AM, Sampliner RE. Plasmapheresis of hepatitis B surface antigen carriers. Acta Haematol Pol. 1980 Apr-Jun; 11(2):73-8.
        View in: PubMed
      95. Tong MJ, Weiner JM, Ashcavai MW, Vyas GN. Evidence for clustering of hepatitis B virus infection in families of patients with primary hepatocellular carcinoma. Cancer. 1979 Dec; 44(6):2338-4.
        View in: PubMed
      96. Tong MJ, Weiner JM, Ashcavai MW, Redeker AG, Comparini S, Vyas GN. A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis. 1979 Oct; 140(4):506-12.
        View in: PubMed
      97. Chien DY, Vyas GN. Correlation of the hepatitis B surface and e antigens. N Engl J Med. 1978 Nov 30; 299(22):1253-4.
        View in: PubMed
      98. Grady GF, Lee VA, Prince AM, Gitnick GL, Fawaz KA, Vyas GN, Levitt MD, Senior JR, Galambos JT, Bynum TE, Singleton JW, Clowdus BF, Akdamar K, Aach RD, Winkelman EI, Schiff GM, Hersh T. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis. 1978 Nov; 138(5):625-38.
        View in: PubMed
      99. Prince AM, Szmuness W, Mann MK, Vyas GN, Grady GF, Shapiro FL, Suki WN, Freidman EA, Avram MM, Stenzel KH. Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis. J Infect Dis. 1978 Feb; 137(2):131-44.
        View in: PubMed
      100. Tanno H, Fay O, Findor J, Igartua EB, Roncoroni M, Gerety RJ, Vyas GN. The role of the hepatitis B virus infection in patients with chronic hepatitis in Argentina. J Med Virol. 1978; 3(2):119-23.
        View in: PubMed
      101. Vyas GN, Peterson DL, Townsend RM, Damle SR, Magnius LO. Hepatitis B "e" antigen: an apparent association with lactate dehydrogenase isozyme-5. Science. 1977 Dec 9; 198(4321):1068-70.
        View in: PubMed
      102. Vyas GN, Roberts IM. Radioimmunoassay of hepatitis B core antigen and antibody with autologous reagents. Vox Sang. 1977 Dec; 33(6):369-72.
        View in: PubMed
      103. Peterson DL, Roberts IM, Vyas GN. Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc Natl Acad Sci U S A. 1977 Apr; 74(4):1530-4.
        View in: PubMed
      104. Grady GF, Kaplan MM, Vyas GN. Antibody to hepatitis B core antigen in chronic hepatitis and primary biliary cirrhosis: evaluation by a new autologous solid phase radioimmunoassay. Gastroenterology. 1977 Apr; 72(4 Pt 1):590-3.
        View in: PubMed
      105. Vyas GN, Roberts I, Peterson DL, Holland PV. Nonspecific test reaction for antibodies to hepatitis B surface antigen in chronic HBAg carriers. J Lab Clin Med. 1977 Feb; 89(2):428-32.
        View in: PubMed
      106. Vyas GN, Perkins HA. Letter: Anti-IgA in blood donors. Transfusion. 1976 May-Jun; 16(3):289-90.
        View in: PubMed
      107. Rao KR, Vyas GN. Biochemical characterization of hepatitis B surface antigen in relation to serologic activity. J Biol Stand. 1976; 4(4):295-304.
        View in: PubMed
      108. Prince AM, Szmuness W, Mann MK, Vyas GN, Grady GF, Shapiro FL, Suki WN, Friedman EA, Stenzel KH. Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med. 1975 Nov 20; 293(21):1063-7.
        View in: PubMed
      109. Vyas GN, Roberts I, MacKay IR, Gust ID. Immunologic mechanisms in hepatitis B assayed by antigen-binding lymphocytes. Am J Med Sci. 1975 Sep-Oct; 270(2):241-6.
        View in: PubMed
      110. Magnius L, Kaplan L, Vyas GN, Perkins HA. A new virus specified determinant of hepatitis B surface antigen. Acta Pathol Microbiol Scand B. 1975 Jun; 83(3):295-7.
        View in: PubMed
      111. Vyas GN, Perkins HA, Yang YM, Basantani GK. Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J Lab Clin Med. 1975 May; 85(5):838-42.
        View in: PubMed
      112. Roberts IM, Bernard CC, Vyas GN, Mackay IR. T-cell dependence of immune response to hepatitis B antigen in mice. Nature. 1975 Apr 17; 254(5501):606-7.
        View in: PubMed
      113. Vyas GN, Basantani GK, Perkins HA. Letter: Hepatitis in selective IgA deficiency? Br Med J. 1975 Mar 29; 1(5960):736.
        View in: PubMed
      114. Greeman RL, Robinson WS, Vyas GN. A sensitive test for antibody against the hepatitis B core antigen (anti-HB-c). Vox Sang. 1975; 29(1):77-80.
        View in: PubMed
      115. Vyas GN, Schmid R, Ibrahim AB, Rao KR. Specific immunotherapy proposed for hepatitis B virus infection. Dev Biol Stand. 1975; 30:350-6.
        View in: PubMed
      116. Ibrahim AB, Vyas GN, Perkins HA. Immune response to hepatitis B surface antigen. Infect Immun. 1975 Jan; 11(1):137-41.
        View in: PubMed
      117. Rao KR, Vyas GN. Hepatitis B surface antigen (HBs Ag): tryptophan content and biological activity. J Gen Virol. 1974 Sep; 24(3):571-3.
        View in: PubMed
      118. Vyas GN, Ibrahim AB, Rao KR, Schmid R. Tolerance to hepatitis B antigen: a hypothesis for its termination with 'immune-RNA'. Life Sci. 1974 Jul 15; 15(2):261-6.
        View in: PubMed
      119. Ibrahim AB, Vyas GN, Prince AM. Studies on delayed hypersensitivity to hepatitis B antigen in chimpanzees. Clin Exp Immunol. 1974 Jun; 17(2):311-8.
        View in: PubMed
      120. Rao KR, Vyas GN. Structure and activity of hepatitis B antigen (HBAg). 2. Amino acid composition of an active subunit of HBAg. Microbios. 1974 May; 10(40):233-8.
        View in: PubMed
      121. Perkins HA, Perkins SL, Vyas GN. Further evaluation of a latex agglutination test for detection of hepatitis B antigen. Transfusion. 1974 May-Jun; 14(3):287-90.
        View in: PubMed
      122. Vyas GN. Evidence against recessive inheritance of susceptibility to the chronic carrier state for hepatitis B antigen. Nature. 1974 Mar 8; 248(444):159-60.
        View in: PubMed
      123. Rao KR, Vyas GN. Structure and activity of hepatitis B antigen (HBAg). 1. Studies on some conformational aspects and chemical modification of hepatitis B antigen. Microbios. 1974 Mar-Apr; 9(36):239-45.
        View in: PubMed
      124. Szmuness W, Prince AM, Grady GF, Mann MK, Levine RW, Friedman EA, Jacobs MJ, Josephson A, Ribot S, Shapiro FL, Stenzel KH, Suki WN, Vyas G. Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA. 1974 Feb 25; 227(8):901-6.
        View in: PubMed
      125. Vyas GN, Ibrahim AB, Rao KR, Likhite V. In vitro transfer of cell-mediated immunity to hepatitis B antigen with RNA. Nature. 1974 Feb 8; 247(440):377-8.
        View in: PubMed
      126. Berg JV, Berntsen KO, Björling H, Holmström B, Vyas GN. Recovery of hepatitis B antibody from human plasma products separated by a modified Cohn fractionation. Vox Sang. 1974; 27(4):302-9.
        View in: PubMed
      127. Vyas GN, Adelberg SG, Perkins HA. Letter: Nonspecificity of hepatitis B antigen detected with iodine-125-labeled antibody. Science. 1973 Dec 28; 182(4119):1368-71.
        View in: PubMed
      128. Ibrahim AB, Vyas GN. A simple inexpensive method for demonstrating in vitro leukocyte migration. Vox Sang. 1973 Dec; 25(6):552-6.
        View in: PubMed
      129. Rao KR, Vyas GN. Hepatitis B antigen activity in protein subunits produced by sonicaation. Nat New Biol. 1973 Feb 21; 241(112):240-1.
        View in: PubMed
      130. Vyas GN, Rao KR, Ibrahim AB. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science. 1972 Dec 22; 178(4067):1300-1.
        View in: PubMed
      131. Pai MK, Zipursky A, Vyas GN. Antibodies to IGA in pregnancy and in recipient of Rh o (D) immune globulin (human). Transfusion. 1972 Nov-Dec; 12(6):394-9.
        View in: PubMed
      132. Vyas GN. Hepatitis B antigen and antibodies: detection by hemagglutination assay. Am J Med Technol. 1972 Sep; 38(9):366-9.
        View in: PubMed
      133. Vyas GN, Williams EW, Klaus GG, Bond HE. Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol. 1972 Apr; 108(4):1114-8.
        View in: PubMed
      134. Shaffer WE, Vyas GN, Shahed A, Chen E, Perkins HA. Comparison of counterelectrophoresis and hemagglutination inhibition tests for hepatitis-associated antigen. Vox Sang. 1972; 22(4):366-70.
        View in: PubMed
      135. Schuh V, Vyas GN, Fudenberg HH. Study of a French family with a new variant of blood group A: A lae . Am J Hum Genet. 1972 Jan; 24(1):11-7.
        View in: PubMed
      136. Faulk WP, Vyas GN, Phillips CA, Fudenberg HH, Chism K. Passive haemagglutination test for anti-rhinovirus antibodies. Nat New Biol. 1971 May 26; 231(21):101-4.
        View in: PubMed
      137. Leikola J, Fudenberg HH, Vyas GN, Perkins HA. Isoantibodies to human IgM: serologic and immunochemical investigations. J Immunol. 1971 May; 106(5):1147-53.
        View in: PubMed
      138. Leikola J, Vyas GN. Human antibodies to ruminant IgM concealing the absence of IgA in man. J Lab Clin Med. 1971 Apr; 77(4):629-38.
        View in: PubMed
      139. Vyas GN, Shulman NR. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science. 1970 Oct 16; 170(3955):332-3.
        View in: PubMed
      140. Vyas GN, Levin AS, Fudenberg HH. Intrauterine isoimmunization caused by maternal IgA crossing the placenta. Nature. 1970 Jan 17; 225(5229):275-6.
        View in: PubMed
      141. Vyas GN, Fudenberg HH. Am(1), the first genetic marker of human immunoglobulin A. Proc Natl Acad Sci U S A. 1969 Dec; 64(4):1211-6.
        View in: PubMed
      142. Vyas GN, Holmdahl L, Perkins HA, Fudenberg HH. Serologic specificity of hun anti-IgA and its significance in transfusion. Blood. 1969 Nov; 34(5):573-81.
        View in: PubMed
      143. Vyas GN, Fudenberg HH. Isoimmune anti-IgA causing anaphylactoid transfusion reactions. N Engl J Med. 1969 May 8; 280(19):1073-4.
        View in: PubMed
      144. Vyas GN, Fudenberg HH. Evolutionary dissociation of gamma G2 and Gm (n) antigens. Vox Sang. 1969 Mar; 16(3):233-6.
        View in: PubMed
      145. Vyas GN, Fudenberg HH, Sassetti RJ, Petz LD. Experimental study of aldomet-induced positive antiglobulin reaction. I. Br J Haematol. 1969 Jan-Feb; 16(1):137-43.
        View in: PubMed
      146. Vyas GN, Perkins HA, Fudenberg HH. Anaphylactoid transfusion reactions associated with anti-IgA. Lancet. 1968 Aug 10; 2(7563):312-5.
        View in: PubMed
      147. Vyas GN, Munver UL, Salgaonkar DS, Purandare NM. Human cadaver blood for transfusion. Transfusion. 1968 Jul-Aug; 8(4):250-3.
        View in: PubMed
      148. Fudenberg HH, Gold ER, Vyas GN, Mackenzie MR. Human antibodies to human IgA globulins. Immunochemistry. 1968 Mar; 5(2):203-6.
        View in: PubMed
      149. Vyas GN, Fudenberg HH, Pretty HM, Gold ER. A new rapid method for genetic typing of human immunoglobulins. J Immunol. 1968 Feb; 100(2):274-9.
        View in: PubMed
      150. Vyas GN, Fudenberg HH. Use of B. subtilis neutral proteinase in blood group serology. Vox Sang. 1968; 15(4):300-3.
        View in: PubMed
      151. Sathe MS, Vyas GN, Bhatia HM, Purandare NM. Hemagglutinating substances in plant seeds. J Postgrad Med. 1967 Jan; 13(1):29-36.
        View in: PubMed
      152. VYAS GN, SATHE MS, PURANDARE NM, SATOSKAR RS. RED CELL, PLASMA AND BLOOD VOLUME MEASURED BY RADIOCHROMIUM LABELLED CELLS AND HAEMATOCRIT IN INDIANS BELONGING TO LOW AND HIGH SOCIO-ECONOMIC GROUPS. Indian J Med Res. 1965 Feb; 53:122-39.
        View in: PubMed
      153. VYAS GN, PANDIT HM, PURANDARE NM. Suppression of gene A in two cases of anti-H (Bombay bloods) in a family from South Canara. J Assoc Physicians India. 1962 Dec; 10:745-8.
        View in: PubMed
      154. VYAS GN, BHATIA HM, SUKUMARAN PK, BALKRISHANAN V, SANGHVI LD. Study of blood groups, abnormal hemoglobins and other genetical characters in some tribes of Gujarat. Am J Phys Anthropol. 1962 Sep; 20:255-65.
        View in: PubMed
      155. HAKIM SA, VYAS GN, SANGHVI LD, BHATIA HM. Eleven cases of "Bombay" phenotype in six families: suppression of ABO antigen demonstrated in two families. Transfusion. 1961 Jul-Aug; 1:218-22.
        View in: PubMed
      156. VYAS GN, BHATIA HM, SANGHVI LD. Three cases of weak B in an Indian family. Vox Sang. 1960 Sep; 5:509-16.
        View in: PubMed
      157. VYAS GN, BHATIA HM, BANKER DD, PURANDARE NM. Study of blood groups and other genetical characters in six Gujarati endogamous groups in Western India. Ann Hum Genet. 1958 May; 22(3):185-99.
        View in: PubMed
      158. VYAS GN, SHAH NM. Chalkones from quinacetophenone monomethyl ether. Curr Sci. 1950 Oct; 19(10):318-9.
        View in: PubMed
      Girish's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP